Edition:
United States

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

30.19USD
26 May 2017
Change (% chg)

$-0.32 (-1.05%)
Prev Close
$30.51
Open
$30.36
Day's High
$30.65
Day's Low
$30.00
Volume
72,810
Avg. Vol
101,655
52-wk High
$32.51
52-wk Low
$16.39

CSII.OQ

Chart for CSII.OQ

About

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral... (more)

Overall

Beta: 2.59
Market Cap(Mil.): $987.58
Shares Outstanding(Mil.): 32.71
Dividend: --
Yield (%): --

Financials

  CSII.OQ Industry Sector
P/E (TTM): -- 31.44 17.41
EPS (TTM): -0.23 -- --
ROI: -5.77 12.84 -5.42
ROE: -6.92 15.33 -4.68

BRIEF-Cardiovascular Systems Q3 loss per share $0.05

* Cardiovascular Systems Inc reports fiscal 2017 third-quarter financial results

May 03 2017

Cardiovascular Systems must pay $25 million for retaliation - jury

Cardiovascular Systems Inc has been ordered to pay $25.1 million to a former employee who claimed the medical device manufacturer retaliated against him for complaining about what he said was off-label marketing and a scheme to pay doctors kickbacks.

Apr 26 2017

BRIEF-Cardiovascular Systems updates on former employee case

* Cardiovascular Systems says jury awarded plaintiff $2.7 million compensatory damages for claims for whistleblower retaliation, wrongful termination

Apr 26 2017

Judge tosses Cardiovascular Systems investors' kickback case

Cardiovascular Systems Inc has won the dismissal of a class action lawsuit accusing the medical-device maker of failing to disclose to investors that it relied on illegal kickbacks to doctors and off-label promotions to drive up sales.

Mar 30 2017

BRIEF-Cardiovascular Systems receives approval for Diamondback 360 coronary orbital atherectomy system Micro Crown in the United States

* Cardiovascular Systems, Inc. receives approval for the Diamondback 360® coronary orbital atherectomy system (oas) micro crown in the United States

Mar 30 2017

BRIEF-Cardiovascular Systems says Martha Goldberg Aronson joins board

* Cardiovascular systems announces healthcare veteran Martha Goldberg Aronson joins board of directors Source text for Eikon: Further company coverage:

Feb 21 2017

BRIEF-Cardiovascular Systems reports Q2 earnings per share $0.03

* Q2 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S

Jan 25 2017

More From Around the Web

Earnings vs. Estimates